Les rôles distincts des isoformes de myosine II non-musculaire dans des processus cellulaires impliquant le cytosquelette d'actine
We are interested in studying the modulation of the actomyosin complex which is involved in different cellular processes such as cell locomotion and apoptosis. The actomyosin complex is formed by the association of actin filaments and myosin II. The non-muscle myosin II is a hexamer formed by one pair of heavy chains (MHCs) and two pairs of light chain (MLC20 and MLC17). The actomyosin activity is dependent on MLC20 and MHCs phosphorylation. There are three isoforms of MHCs (MHCIIA, MHCIIB and MHCIIC) which have common but also distinctive roles in several cellular processes. Our aim is to clarify the structural and contractile functions of each isoforme of myosin II in different cellular processes, in particular, cell contraction and cell morphology. First, we studied the implication of myosin II isoforms in cell shrinkage and detachment during apoptosis which are both dependent on actomyosin contractility. We treated four different cell lines with TNFα in combination with cycloheximide (CHX) to trigger apoptosis. We confirmed that TNFα induced caspase-3 activation, ROCK1 cleavage and increased MLC20 phosphorylation. We showed that TNFα/CHX induced the caspase-dependent MHCIIA degradation, whereas MHCIIB levels and association with the actin cytoskeleton remained virtually unchanged. Cell shrinkage and detachment were blocked by caspase and ROCK1 inhibitors. Using the MHCIIB (-/-) cell line, we observed that the absence of MHCIIB did not affect cell death rate. However, MHCIIB (-/-) fibroblasts showed more resistance to TNFα-induced actin disassembly, cell shrinkage and detachment than wild type (Wt) fibroblasts, indicating the participation of MHCIIB in these events.   PKCζ, which only phosphorylates MHCIIB, was cleaved during apoptosis, co-immunoprecipitated preferentially with MHCIIB and, interestedly, PKCζ inhibition blocked TNFα-induced shrinkage and detachment. Our results demonstrate that MHCIIB, together with MLC phosphorylation and actin, constitute the actomyosin cytoskeleton that mediates contractility during apoptosis. Second, we studied the involvement of myosin II isoforms in cell shape modulation. Fibroblasts MHCIIB (-/-) spontaneously formed lamellipodia whereas Wt fibroblasts presented a stellate shape. Cortactin was associated with the leading edge of lamellipodia in MHCIIB (-/-) fibroblasts, but it localised diffusely in the cytoplasm or at the end of fine cellular projections in Wt fibroblasts. The levels of cortactin and cortactin phosphorylated in Tyr421 associated with membrane in MHCIIB (-/-) fibroblasts were higher than in Wt fibroblasts. Confocal microscopy showed cortactin/MHCIIA colocalization in wild type but not in MHCIIB (-/-) fibroblasts. bFGF activates Erk1/2 in wild type and MHCIIB (-/-) fibroblasts and  induces the formation of aberrant membrane projections in MHCIIB (-/-) fibroblasts.  In conclusion, our results contribute to characterize the structural and contractile role of each myosin II isoforms in the physiology of the cell.
actin cytoskeleton nonmuscle myosin II actomyosin complex cell contraction apoptosis cortactin GTPase Rac1 GTPase Rac1 lamellipodia formation